Two-dose recombinant shingles vaccine found to be effective even accounting for prior receipt of live shingles vaccine

A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup